Trial Profile
Phase I/IIa trial of CYT 009 GhrQb in obese patients.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 18 Aug 2011
Price :
$35
*
At a glance
- Drugs CYT 009 GhrQb (Primary)
- Indications Obesity
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- Sponsors Cytos Biotechnology
- 27 Apr 2007 New trial record.